دورية أكاديمية
The potential of helical tomotherapy in the treatment of head and neck cancer.
| العنوان: | The potential of helical tomotherapy in the treatment of head and neck cancer. |
|---|---|
| المؤلفون: | Van Gestel D; Department of Radiotherapy, University Radiotherapy Antwerp, Antwerp, Belgium. dirk.vangestel@zna.be, Verellen D, Van De Voorde L, de Ost B, De Kerf G, Vanderveken O, Van Laer C, Van den Weyngaert D, Vermorken JB, Gregoire V |
| المصدر: | The oncologist [Oncologist] 2013 Jun; Vol. 18 (6), pp. 697-706. Date of Electronic Publication: 2013 May 30. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2022- : Oxford : Oxford University Press Original Publication: Dayton, Ohio : AlphaMed Press, c1996- |
| مواضيع طبية MeSH: | Head and Neck Neoplasms/*radiotherapy , Radiotherapy, Image-Guided/*methods , Radiotherapy, Intensity-Modulated/*methods, Head and Neck Neoplasms/pathology ; Humans ; Radiotherapy Dosage ; Randomized Controlled Trials as Topic ; Tomography, X-Ray Computed |
| مستخلص: | A decade after its first introduction into the clinic, little is known about the clinical impact of helical tomotherapy (HT) on head and neck cancer (HNC) treatment. Therefore, we analyzed the basics of this technique and reviewed the literature regarding HT's potential benefit in HNC. The past two decades have been characterized by a huge technological evolution in photon beam radiotherapy (RT). In HNC, static beam intensity-modulated radiotherapy (IMRT) has shown superiority over three-dimensional conformal RT in terms of xerostomia and is considered the standard of care. However, the next-generation IMRT, the rotational IMRT, has been introduced into the clinic without any evidence of superiority over static beam IMRT other than being substantially faster. Of these rotational techniques, HT is the first system especially developed for IMRT in combination with image-guided RT. HT is particularly promising for the treatment of HNC because its sharp dose gradients maximally spare the many radiosensitive organs at risk nearby. In addition, HT's integrated computed tomography scan assures a very precise dose administration and allows for some adaptive RT. Because HT is specifically developed for IMRT in combination with (integrated) image-guidance, it allows for precise dose distribution ("dose painting"), patient setup, and dose delivery. As such, it is an excellent tool for difficult HNC irradiation. The literature on the clinical results of HT in HNC all show excellent short-term (≤2 years) results with acceptable toxicity profiles. However, properly designed trials are still warranted to further substantiate these results. |
| References: | Radiother Oncol. 2008 Oct;89(1):89-96. (PMID: 18524401) Lancet Oncol. 2011 Feb;12(2):127-36. (PMID: 21236730) J Clin Oncol. 2007 Nov 1;25(31):4873-9. (PMID: 17971582) J Cancer Res Ther. 2010 Apr-Jun;6(2):194-8. (PMID: 20622367) Med Phys. 2010 Mar;37(3):1350-9. (PMID: 20384272) Strahlenther Onkol. 2010 May;186(5):280-8. (PMID: 20437018) Radiother Oncol. 2009 Oct;93(1):57-63. (PMID: 19410316) Strahlenther Onkol. 2010 Sep;186(9):511-6. (PMID: 20803182) Int J Radiat Oncol Biol Phys. 1996 Dec 1;36(5):999-1004. (PMID: 8985019) Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1535-9. (PMID: 15925457) Int J Radiat Oncol Biol Phys. 2011 Feb 1;79(2):450-8. (PMID: 20381266) Radiother Oncol. 2004 Feb;70(2):189-98. (PMID: 15028407) J Appl Clin Med Phys. 2009 Oct 07;10(4):117-131. (PMID: 19918236) Int J Radiat Oncol Biol Phys. 2006 Jul 1;65(3):917-23. (PMID: 16751074) Radiother Oncol. 2012 Sep;104(3):343-8. (PMID: 22853852) Radiother Oncol. 2008 Jan;86(1):86-92. (PMID: 18054102) Med Phys. 2012 Nov;39(11):6531-3. (PMID: 23127047) Phys Med Biol. 2010 Jun 7;55(11):N329-36. (PMID: 20442461) J Cancer Res Ther. 2009 Apr-Jun;5(2):107-12. (PMID: 19542666) Radiat Oncol. 2013 Feb 20;8:37. (PMID: 23425449) Radiother Oncol. 2007 Feb;82(2):174-8. (PMID: 17275112) N Engl J Med. 2007 Oct 25;357(17):1695-704. (PMID: 17960012) Phys Med Biol. 2007 Jul 21;52(14):4137-53. (PMID: 17664599) Radiother Oncol. 1988 Jun;12(2):129-40. (PMID: 3406458) N Engl J Med. 2007 Oct 25;357(17):1705-15. (PMID: 17960013) Med Phys. 2008 Jan;35(1):310-7. (PMID: 18293586) Radiat Oncol. 2012 Jul 31;7:120. (PMID: 22849723) Technol Cancer Res Treat. 2009 Apr;8(2):115-22. (PMID: 19334792) BMC Cancer. 2006 Jan 31;6:28. (PMID: 16448551) Radiother Oncol. 2010 Feb;94(2):199-205. (PMID: 20083316) Int J Radiat Oncol Biol Phys. 1997 Aug 1;39(1):99-114. (PMID: 9300745) Semin Radiat Oncol. 2005 Jul;15(3):168-79. (PMID: 15983942) Phys Med Biol. 1995 Sep;40(9):1435-49. (PMID: 8532757) Int J Radiat Oncol Biol Phys. 2001 Oct 1;51(2):332-43. (PMID: 11567806) Cancer. 1994 Oct 1;74(7):1933-8. (PMID: 8082099) Int J Radiat Oncol Biol Phys. 2000 Mar 15;46(5):1117-26. (PMID: 10725621) Int J Radiat Oncol Biol Phys. 2006 Mar 1;64(3):962-7. (PMID: 16458781) Radiat Oncol. 2011 Feb 21;6:20. (PMID: 21338501) Med Phys. 1993 Nov-Dec;20(6):1709-19. (PMID: 8309444) Radiother Oncol. 2002 Aug;64(2):197-204. (PMID: 12242130) Eur Arch Otorhinolaryngol. 2012 Jun;269(6):1703-11. (PMID: 22218846) Int J Radiat Oncol Biol Phys. 2008 Mar 1;70(3):883-91. (PMID: 18164857) Head Neck. 2010 Nov;32(11):1452-9. (PMID: 20146333) Radiother Oncol. 2012 Sep;104(3):286-93. (PMID: 22995588) Med Phys. 2010 Feb;37(2):762-70. (PMID: 20229886) Nat Rev Cancer. 2004 Sep;4(9):737-47. (PMID: 15343280) Int J Radiat Oncol Biol Phys. 2011 Jul 15;80(4):1248-55. (PMID: 20947268) Med Phys. 2007 Jul;34(7):2785-8. (PMID: 17821985) Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):1-7. (PMID: 16618572) Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1129-34. (PMID: 18922651) Oncologist. 2007 May;12(5):555-64. (PMID: 17522243) Radiother Oncol. 2008 Feb;86(2):142-7. (PMID: 18237799) Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S135-9. (PMID: 20171508) Lancet Oncol. 2010 Jan;11(1):85-91. (PMID: 20129131) Cancer Treat Rev. 2010 Aug;36(5):393-9. (PMID: 20181430) Br J Radiol. 2004 Apr;77(916):285-95. (PMID: 15107318) Phys Med Biol. 1998 Jun;43(6):1605-28. (PMID: 9651029) Med Phys. 2006 Jan;33(1):187-97. (PMID: 16485425) Nat Rev Cancer. 2007 Dec;7(12):949-60. (PMID: 18034185) Radiother Oncol. 2012 Sep;104(3):324-30. (PMID: 22236614) Int J Radiat Oncol Biol Phys. 2000 Jun 1;47(3):551-60. (PMID: 10837935) Oncologist. 2005 Mar;10(3):215-24. (PMID: 15793225) N Engl J Med. 2004 May 6;350(19):1937-44. (PMID: 15128893) Radiother Oncol. 1999 Dec;53(3):199-203. (PMID: 10660198) J Appl Clin Med Phys. 2006 Aug 24;7(3):1-11. (PMID: 17533339) Technol Cancer Res Treat. 2011 Jun;10(3):259-66. (PMID: 21517132) Lancet. 2006 Sep 2;368(9538):843-54. (PMID: 16950362) Radiother Oncol. 2006 Mar;78(3):276-82. (PMID: 16546279) Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):252-9. (PMID: 19362244) Strahlenther Onkol. 2010 Sep;186(9):502-10. (PMID: 20803184) Int J Radiat Oncol Biol Phys. 2003 Jun 1;56(2):573-85. (PMID: 12738335) Technol Cancer Res Treat. 2011 Apr;10(2):171-7. (PMID: 21381795) Int J Radiat Oncol Biol Phys. 2010 Mar 15;76(4):1266-73. (PMID: 19910128) Med Phys. 2005 Jun;32(6):1473-84. (PMID: 16013703) Med Dosim. 2010 Summer;35(2):108-14. (PMID: 19931022) Int J Radiat Oncol Biol Phys. 2010 Dec 1;78(5):1541-7. (PMID: 21092834) Ann Oncol. 2005;16 Suppl 2:ii258-64. (PMID: 15958469) Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):589-96. (PMID: 18793962) Int J Radiat Oncol Biol Phys. 2011 Jun 1;80(2):522-31. (PMID: 20646862) Radiother Oncol. 2011 Dec;101(3):388-93. (PMID: 21962821) Ann Oncol. 2004 Mar;15(3):383-8. (PMID: 14998839) Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1425-39. (PMID: 15590174) Int J Radiat Oncol Biol Phys. 2003 Feb 1;55(2):312-21. (PMID: 12527043) Int J Radiat Oncol Biol Phys. 2000 Feb 1;46(3):619-30. (PMID: 10701741) Med Phys. 2007 Jul;34(7):2691-703. (PMID: 17821977) Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):7-16. (PMID: 10924966) J Clin Oncol. 2008 Aug 1;26(22):3770-6. (PMID: 18669465) N Engl J Med. 2004 May 6;350(19):1945-52. (PMID: 15128894) Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1260-9. (PMID: 19251098) Lancet. 2000 Mar 18;355(9208):949-55. (PMID: 10768432) N Engl J Med. 2006 Feb 9;354(6):567-78. (PMID: 16467544) Radiother Oncol. 2009 Jul;92(1):4-14. (PMID: 19446902) J Clin Oncol. 2006 Jun 10;24(17):2618-23. (PMID: 16763274) Phys Med Biol. 2009 Jan 7;54(1):N9-20. (PMID: 19075362) Int J Radiat Oncol Biol Phys. 2006 Nov 15;66(4):981-91. (PMID: 17145528) |
| فهرسة مساهمة: | Keywords: Head and neck cancer; Helical tomotherapy |
| تواريخ الأحداث: | Date Created: 20130601 Date Completed: 20140213 Latest Revision: 20240321 |
| رمز التحديث: | 20240321 |
| مُعرف محوري في PubMed: | PMC4063397 |
| DOI: | 10.1634/theoncologist.2012-0424 |
| PMID: | 23723331 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1549-490X |
|---|---|
| DOI: | 10.1634/theoncologist.2012-0424 |